Cellebrite DI (CLBT) Cost of Revenue: 2020-2025

Historic Cost of Revenue for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $20.3 million.

  • Cellebrite DI's Cost of Revenue rose 31.53% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.1 million, marking a year-over-year increase of 22.08%. This contributed to the annual value of $132.4 million for FY2024, which is 19.47% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Cost of Revenue is $20.3 million, which was up 14.92% from $17.7 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Cost of Revenue registered a high of $20.3 million during Q3 2025, and its lowest value of $8.2 million during Q1 2021.
  • Over the past 3 years, Cellebrite DI's median Cost of Revenue value was $15.4 million (recorded in 2024), while the average stood at $15.6 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 33.96% in 2022, then declined by 11.39% in 2023.
  • Cellebrite DI's Cost of Revenue (Quarterly) stood at $12.3 million in 2021, then dropped by 1.66% to $12.1 million in 2022, then grew by 22.96% to $14.9 million in 2023, then rose by 18.16% to $17.6 million in 2024, then soared by 31.53% to $20.3 million in 2025.
  • Its Cost of Revenue was $20.3 million in Q3 2025, compared to $17.7 million in Q2 2025 and $17.5 million in Q1 2025.